TCH Regimen - CISMeF

Preferred Label : TCH Regimen;

NCIt synonyms : Taxotere-Carboplatin-Herceptin Regimen; Docetaxel/Doxorubicin/Cyclophosphamide; Docetaxel-Carboplatin-Trastuzumab Regimen; Docetaxel/Carboplatin Trastuzumab; TCH; Docetaxel/Carboplatin Plus Trastuzumab;

NCIt related terms : TCH (Docetaxel, Carboplatin); TCbH (Docetaxel) (trastuzumab-dttb); TCbH (Docetaxel) (trastuzumab-pkrb); TCbH (Docetaxel) (trastuzumab-zerc); TCbH (Docetaxel) (trastuzumab-dkst); TCbH (Docetaxel) (trastuzumab-qyyp); TCbH (Docetaxel) (trastuzumab-anns); TCbH (Docetaxel) (trastuzumab-herw);

NCIt definition : A regimen consisting of docetaxel, carboplatin and trastuzumab that can be used in the treatment of breast cancer.;

NCIt note : Source: NCCN Guidelines 2017;

Codes from synonyms : 9487; 129445; 129348; 128863; 129251; 129154; 129057; 128960;

Details

Origin ID

C63424;

UMLS CUI

C1883258;

Est indiqué pour
- Early-Stage HER2 Positive Breast Cancer [Indication]
Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Carboplatin [NCIt concept]
- Docetaxel [NCIt concept]
- Trastuzumab [NCIt concept]
concept_is_in_subset
- HemOnc Regimen Terminology [NCIt concept]
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]
regimen_has_accepted_use_for_disease
- HER2-Positive Breast Carcinoma [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients